CRESPIATICO ILARIA
- U08, Floor: 4, Room: 4041
Publications
Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Detail
Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Detail
(2023). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2023). Detail
Aroldi, A., Angaroni, F., D’Aliberti, D., Spinelli, S., Crespiatico, I., Crippa, V., et al. (2023). Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. VIRUSES, 15(1) [10.3390/v15010007]. Detail
Fontana, D., Crespiatico, I., Crippa, V., Malighetti, F., Villa, M., Angaroni, F., et al. (2023). Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. NATURE COMMUNICATIONS, 14(1) [10.1038/s41467-023-41670-3]. Detail